Reacción a "Reactions to the phase 1 clinical trial studying the use of the hallucinogen psilocybin for anorexia"

Anorexia nervosa is a serious illness and the treatments available to us have limited efficacy, so I welcome any news about new treatments. However, it is important to stress that the Peck et al. study is very early, very small, with no control group, and basically just wanted to find out whether psilocybin is a safe and tolerable treatment. The study also noted that four patients improved, but we do not know whether this was due to psilocybin, psychological support or simply by chance. For this reason, we should avoid getting our hopes up too high until there are larger, control group studies.